IL18 and metabolic disease: Building on a previous report linking IL18 deficiency to metabolic disorders and depressive-like behavioral changes, we describe here the relationship between IL18 and cancer tumorigenesis, and the potential for IL18 treatment of cancer immunotherapy in combination with immune checkpoint inhibitors.